These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35284610)

  • 1. Statin-naïve anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibody-positive necrotizing myopathy with heliotropic pseudoangioedema.
    Ortiz C; Candela B; Bowers L; Cai E; English JC
    JAAD Case Rep; 2022 Mar; 21():198-200. PubMed ID: 35284610
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
    Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
    J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-associated immune-mediated necrotizing myositis in Native Americans.
    Muruganandam M; Iqbal A; Akpan EB; Dolomisiewicz AC; Waters YM; Emil NS; Nunez SE; McElwee MK; O'Sullivan FX; Fields RA; Sibbitt WL
    Rheumatology (Oxford); 2022 Nov; 61(12):4855-4862. PubMed ID: 35348616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report.
    Lim D; Landon-Cardinal O; Ellezam B; Belisle A; Genois A; Sirois J; Bourré-Tessier J
    SAGE Open Med Case Rep; 2020; 8():2050313X20984120. PubMed ID: 33447390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
    Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy: A Case Report.
    Tokunaga Y; Akiyama M; Nakano K; Konaka K; Taguchi A; Maeda T; Sato R; Kanda T; Nakamura Y; Yujiri T; Ohta Y
    Intern Med; 2024 Jul; ():. PubMed ID: 38987186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy.
    Ghazal F; Zur M; Silver A
    Cureus; 2023 Jan; 15(1):e34121. PubMed ID: 36843759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
    Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing Myopathy.
    Khan N; Kazmi Z
    Qatar Med J; 2022; 2022(1):6. PubMed ID: 35261909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
    Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
    Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness.
    Fink NS; Abubshait L; Deshisky A
    Cureus; 2024 May; 16(5):e61094. PubMed ID: 38919212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
    Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
    Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy.
    Kurashige T; Nakamura R; Murao T; Mine N; Sato M; Katsumata R; Kanaya Y; Dodo Y; Sugiura T; Ohshita T
    BMC Immunol; 2024 May; 25(1):30. PubMed ID: 38734636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
    Kishi T; Rider LG; Pak K; Barillas-Arias L; Henrickson M; McCarthy PL; Shaham B; Weiss PF; Horkayne-Szakaly I; Targoff IN; Miller FW; Mammen AL;
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1088-1094. PubMed ID: 28129483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
    Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies.
    Julien S; Challier I; Malleter M; Jouen F; Drouot L; Boyer O
    Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.